S+T With ET in 1L Advanced SCLC
KEY TAKEAWAYS The phase I/II trial aimed to present updated results on long-term efficacy and...
Read More
Conferences: ESMO-IO 2023
Testing UV1 Vax + Anti-pd-(L)1 in Inoperable NSCLC: LUNGVAC
KEY TAKEAWAYS The LUNGVAC phase II trial aimed to assess efficacy and safety of anti-PD-1...
Read More
Evaluating NIVO + CCR2/5i or Anti-IL8 in NSCLC/HCC
KEY TAKEAWAYS The phase II trial aimed to test anti-CCR2/5i or anti-IL8 with NIVO in resecting...
Read MoreImpact of Nivolumab on NSCLC: Safety & Efficacy
KEY TAKEAWAYS The EVIDENS observational study aimed to investigate nivolumab’s long-term...
Read More
Tumor Microenvironment Variability in HGSC: NeoPembroV Study
KEY TAKEAWAYS The NEOPEMBROV, phase 2 trial, aimed to investigate the impact of sample site...
Read MoreTQB2450+Anlotinib Combo Shows Promise in ESCC
KEY TAKEAWAYS The phase 2 trial aimed to investigate the efficacy and safety of anlotinib combined...
Read More